Systemic gene expression mapping of voltage-gated calcium channel α1-subunits in cats
Takumi Matsuura1, Shohei Morita2, Ryuji Fukushima2
1Toray Industries, Inc., Tokyo, Japan.
Background:
In veterinary medicine, voltage-gated calcium channels (VGCCs) are key drug targets. Calcium channel blockers (CCBs) are the standard treatment for common feline diseases, such as systemic hypertension and hypertrophic cardiomyopathy. However, therapeutic strategies are limited due to the adverse effects of existing drugs like amlodipine, such as activation of the renin-angiotensin-aldosterone system. A critical lack of feline-specific data on the tissue distribution of VGCC subtypes fundamentally hinders the safe and effective application of CCBs in cats. This is because knowledge from other species is often not translatable due to the unique metabolic pathways in cats.
Aim:
To fill this critical data gap, the present study created the first baseline quantitative map of the mRNA expression of seven major VGCC α1-subunits across a comprehensive range of feline tissues.
Methods:
Twelve tissue types were collected from a single 16-month-old male cat. Using a validated TaqMan probe-based quantitative real-time PCR assay, we measured the relative mRNA expression of seven CaV α1-subunit genes: CACNA1S (CaV1.1), CACNA1C (CaV1.2), CACNA1D (CaV1.3), CACNA1F (CaV1.4), CACNA1B (CaV2.2), CACNA1G (CaV3.1), and CACNA1H (CaV3.2). Relative transcript abundance was calculated using the 2-ΔCt method with 18S rRNA as the endogenous control for normalization.
Results:
The seven VGCC genes exhibited distinct, tissue-specific expression patterns. CACNA1S expression was predominantly localized to skeletal muscle. The heart showed the highest expression of CACNA1C and CACNA1H. The brain displayed prominent CACNA1B, CACNA1C, and CACNA1G expression. The mesenteric lymph node also showed significant CACNA1C, CACNA1F, and CACNA1G expression. Conversely, the liver and pancreas consistently displayed very low expression for most of the channel genes investigated.
Conclusion:
This study provides the first foundational mRNA expression map of major VGCC α1-subunits in feline tissues. The results reveal unique expression profiles that highlight both conserved physiological functions and significant differences compared to other species, particularly in cardiac and lymphoid tissues. These molecular data are vital for advancing feline pharmacology by enabling more accurate predictions of the therapeutic and adverse effects of CCBs and provide a critical resource for future investigations into feline channelopathies.
Insights
This study maps voltage-gated calcium channel (VGCC) gene expression in feline tissues, revealing unique patterns crucial for developing safer calcium channel blockers (CCBs) in cats.
Area of Science:
- Veterinary Pharmacology
- Molecular Biology
- Cardiovascular Physiology
Background:
- Voltage-gated calcium channels (VGCCs) are critical drug targets in veterinary medicine, with calcium channel blockers (CCBs) used for feline hypertension and cardiomyopathy.
- Current CCB therapies are limited by adverse effects and a lack of feline-specific data, as cross-species extrapolation is unreliable due to unique feline metabolism.
- A significant knowledge gap exists regarding the tissue distribution of VGCC subtypes in cats, hindering safe and effective drug application.
Purpose of the Study:
- To establish the first quantitative mRNA expression map of seven major VGCC α1-subunits in a comprehensive range of feline tissues.
- To address the critical need for feline-specific data to improve the safety and efficacy of CCBs.
- To provide foundational molecular data for future research into feline channelopathies.
Main Methods:
- Quantitative real-time PCR (qPCR) was employed using validated TaqMan probes to measure mRNA expression.
- Seven key VGCC α1-subunit genes (CACNA1S, CACNA1C, CACNA1D, CACNA1F, CACNA1B, CACNA1G, CACNA1H) were analyzed.
- mRNA expression was quantified across twelve diverse feline tissue types, normalized to 18S rRNA.
Main Results:
- Distinct tissue-specific expression patterns were observed for the seven VGCC genes.
- CACNA1S was predominantly found in skeletal muscle; CACNA1C and CACNA1H showed high expression in the heart.
- The brain exhibited significant expression of CACNA1B, CACNA1C, and CACNA1G, while mesenteric lymph nodes showed notable CACNA1C, CACNA1F, and CACNA1G expression. Liver and pancreas had low expression.
Conclusions:
- This study presents the first comprehensive mRNA expression map of major VGCC α1-subunits in feline tissues.
- The unique expression profiles highlight conserved functions and species-specific differences, particularly in cardiac and lymphoid tissues.
- These findings are vital for advancing feline pharmacology, predicting CCB effects, and guiding future research on feline channelopathies.
More Related Videos
Related Concept Videos
01:26Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:24Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
01:12Mechanically-gated Ion Channels
01:19Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
01:21G-Protein Gated Ion Channels
Sensory...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism